Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3186
+0.0053 (1.69%)
At close: Jun 6, 2025, 4:00 PM
0.3100
-0.0086 (-2.70%)
After-hours: Jun 6, 2025, 7:57 PM EDT
Ovid Therapeutics Stock Forecast
OVID's stock price has decreased by -89.66% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Ovid Therapeutics stock ranges from a low of $1.20 to a high of $4.00. The average analyst price target of $2.78 forecasts a 772.57% increase in the stock price over the next year.
Price Target: $2.78 (+772.57%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ovid Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $1.5 | Strong Buy | Maintains | $2 → $1.5 | +370.81% | May 27, 2025 |
| BTIG | BTIG | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +1,155.49% | Mar 24, 2025 |
| Wedbush | Wedbush | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +841.62% | Mar 12, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $4 | Hold → Buy | Upgrades | $4 | +1,155.49% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +841.62% | Dec 4, 2024 |
Financial Forecast
Revenue This Year
262.65K
from 566.00K
Decreased by -53.60%
Revenue Next Year
336.60K
from 262.65K
Increased by 28.16%
EPS This Year
-0.62
from -0.37
EPS Next Year
-0.69
from -0.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 577,500 | 735,000 | 367,500 | ||
| Avg | 262,650 | 336,600 | 119,003 | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.0% | 179.8% | 9.2% | ||
| Avg | -53.6% | 28.2% | -64.6% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.53 | -0.56 | -0.83 |
| Avg | -0.62 | -0.69 | -0.93 |
| Low | -0.71 | -0.74 | -1.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.